Skip to main content
Clinical Trials/NCT06549179
NCT06549179
Recruiting
Not Applicable

Validation Study of the Screening Performance of the French Version of the Autism Mental Status Examination Scale as a Tool for Identifying Autism Spectrum Disorder in Adults

Assistance Publique - Hôpitaux de Paris1 site in 1 country410 target enrollmentNovember 4, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
410
Locations
1
Primary Endpoint
Accuracy of the AMSE tool rated by a non-expert psychiatrist or psychologist but trained to in ASD diagnosis and to the tool, and considered here as the index test, in identifying ASD in adults.
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

To improve diagnosis of Autism Spectrum Disorder (ASD), expert centers have been set up in France since 2000/2010. However, waiting times in these centers are long, mean of 19 months for adults, and more than half the people seen do not end up with an ASD, even though referral by a psychiatrist is increasingly required.

Therefore, validated diagnostic tools for screening before referral are needed. The Autism Mental Status Exam (AMSE), a 8-item tool, which is quick and easy to use, appears to have excellent sensitivity (0.91) and specificity (0.93). However, this tool was only evaluated when used by experts and on a sample of 50 patients.

The hypothesis of this study is that the AMSE, used by non-expert psychiatrists, has sufficiently good diagnostic performance (minimal sensitivity and specificity of respectively 93% and 65%) to be used in screening adults with suspected ASD.

Detailed Description

Patients who contact one of the expert centers participating in the study for an ASD diagnostic evaluation are first referred, as in usual care, to a non-expert psychiatrist or psychologist (from a list of professionals provided by the center and previously trained to the AMSE) to complete a pre-evaluation file. For the study the AMSE and a brief AMSE-filling guide is added to the file. Seven days to 12 months after, patients have a 2-day (consecutive or separated by a maximum of 2 months) full ASD evaluation in the expert center with a final diagnosis made by the expert multidisciplinary team according to Diagnostic and Statistical Manual (DSM)-5 criteria for ASD.

Registry
clinicaltrials.gov
Start Date
November 4, 2024
End Date
November 1, 2027
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient 18 years of age or older
  • Patient who has requested, either personally, through a relative, or through a healthcare professional, a diagnostic evaluation at a center specializing in ASD diagnosis.
  • Patient covered by national health insurance

Exclusion Criteria

  • Patient who has previously undergone a diagnostic assessment resulting in a diagnosis of Autism Spectrum Disorder (ASD) made by a psychiatrist or child psychiatrist
  • Absence of informed consent (patient or his/her legal guardian)
  • Pregnant or breast-feeding
  • Patient deprived of freedom
  • Non-French-speaking patient and/or parents and/or legal guardians
  • AMSE not, incorrectly or inadequately completed by non-expert psychiatrist or psychologist
  • Patient covered by Aide Medicale d'Etat (AME)

Outcomes

Primary Outcomes

Accuracy of the AMSE tool rated by a non-expert psychiatrist or psychologist but trained to in ASD diagnosis and to the tool, and considered here as the index test, in identifying ASD in adults.

Time Frame: 0-12 months from AMSE rating

Diagnostic performance as measured by sensitivity, specificity, area under the receiver operating characteristic curve for different thresholds, compared to the reference standard. The reference standard is the final diagnosis made by the expert multidisciplinary team according to DSM-5 criteria for ASD, based on all routine assessments, i.e.: anamnesis and use of standardized tools with, at best, Autism Diagnostic Observation Scale (ADOS-2) (if fluid language) and Autism Diagnostic Interview (ADI-R) (if accompanying parent present), or, alternatively : Adult Asperger Assessment (AAA), (ASD-DA), Echelle des Comportements Répétés et Restreints (EC2R), Pervasive Developmental Disorder in Mental Retardation Scale (PDD-MRS).

Secondary Outcomes

  • Accuracy of the AMSE tool, rated by an expert psychiatrist or psychologist, in identifying ASD in adults.(0-12 months from AMSE expert rating)
  • AMSE score according to differential diagnosis(0-12 months from AMSE rating)
  • Exploratory : predictive model of ASD diagnosis(0-12 months from AMSE rating)
  • Other accuracy measures of the AMSE tool rated by a non-expert psychiatrist or psychologist trained to the tool, in identifying ASD in adults.(0-12 months from AMSE rating)
  • Acceptability on the AMSE tool by non-expert psychiatrists or psychologists trained to use the tool.(Immediately after AMSE rating)
  • Feedback on the AMSE tool by non-expert psychiatrists or psychologists trained to use the tool.(Immediately after AMSE rating)
  • Accuracy of the AMSE tool rated by a non-expert psychiatrist or psychologist trained to the tool, in identifying ASD in adults, according to the presence or absence of an intellectual disability (Intellectual coefficient<70 measured on the WAIS-IV).(0-12 months from AMSE rating)
  • Differential diagnoses(0-12 months from AMSE rating)

Study Sites (1)

Loading locations...

Similar Trials